Eva Caamaño Gutiérrez

Dr. Eva Caamaño Gutiérrez

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Trends in Parasitology
Verified
Journal Article
Open access
JSJ. Enrique Salcedo-Sora
J. Enrique Salcedo-Sora
EGEva Caamaño Gutiérrez
Eva Caamaño Gutiérrez
SWStephen A. Ward
Stephen A. Ward
GBGiancarlo Augusto Biagini
Giancarlo Augusto Biagini
We hypothesise that intraerythrocytic malaria parasite metabolism is not merely fulfilling the need for ATP generation, but is evolved to support rapid proliferation, similar to that seen in other rapidly proliferating cells such as cancer cells. Deregulated glycolytic activity coupled with impaired mitochondrial metabolism is a metabolic strategy to generate glycolytic intermediates essential for rapid biomass generation for schizogony. Further, we discuss the possibility that Plasmodium metabolism is not only a functional consequence of the 'hard-wired' genome and argue that metabolism may also have a causal role in triggering the cascade of events that leads to developmental stage transitions. This hypothesis offers a framework to rationalise the observations of aerobic glycolysis, atypical mitochondrial metabolism, and metabolic switching in nonproliferating stages.

7 June 2019 in Amyloid
Verified
Journal Article
Open access
HDHannah A. Davies
Hannah A. Davies
EGEva Caamaño Gutiérrez
Eva Caamaño Gutiérrez
YCYa Hua Chim
Ya Hua Chim
MFMark Field
Mark Field
ONOmar Nawaytou
Omar Nawaytou
Jillian MadineJillian Madine
Jillian Madine
Objective: To explore the relationship of aortic medial amyloid with biochemical and micromechanical properties of the aortic wall in aneurysm patients. Methods: Human aortic tissues removed during aneurysm surgery from tricuspid (idiopathic degenerative aneurysm, DA) and bicuspid valve (BAV) patients were subjected to oscillatory nanoindentation experiments to determine localised mechanical properties of the tissue (shear storage modulus, G´ and shear loss modulus, G˝). Collagen, elastin, matrix metalloproteinase 2 and glycosaminoglycans concentrations were determined, along with relative levels of aortic medial amyloid-related factors (medin, milk fat globule-EGF factor 8, oligomers and fibrils). Measurements were combined with clinical data and statistical analyses performed. Results: The DA cohort can be divided based on their phenotype. One group shared similar characteristics with BAV patients, termed bicuspid like phenotype-tricuspid valve. The second group had high amyloid oligomer species present with a significantly lower G´ (p = .01), indicative of reduced elastic response of the tissue, termed amyloid-rich. Conclusions: We identified a group of DA patients with high amyloid oligomers and altered micromechanical and structural properties of the vessel wall. We propose these findings as a cause for aneurysm formation in these patients. Amyloid is not found in BAV patients, suggesting at least two distinct mechanisms for pathogenesis.

29 October 2017 in Metabolomics
Verified
Journal Article
Open access
PDF file
MPM. M. Phelan
M. M. Phelan
EGEva Caamaño Gutiérrez
Eva Caamaño Gutiérrez
MGM. S. Gant
M. S. Gant
RGR. X. Grosman
R. X. Grosman
Jillian MadineJillian Madine
Jillian Madine
The pathogenicity at differing points along the aggregation pathway of many fibril-forming proteins associated with neurodegenerative diseases is unclear. Understanding the effect of different aggregation states of these proteins on cellular processes is essential to enhance understanding of diseases and provide future options for diagnosis and therapeutic intervention.

30 May 2025 in Thorax
Verified
Journal Article
Open access
PDF file
RMRosemary E Maher
Rosemary E Maher
UCUrszula Cytlak
Urszula Cytlak
SASaad Aleem
Saad Aleem
PBPeter Barry
Peter Barry
DBDaniel Paul Brice
Daniel Paul Brice
RLRobert W Lord
Robert W Lord
Background Despite significant clinical improvements, there is evidence of persisting airway inflammation in people with cystic fibrosis (CF) established on elexacaftor/tezacaftor/ivacaftor (ETI) therapy. As CF is a multi-system disease, systemic immune profiles can reflect local inflammation within the lungs and other organs. Understanding systemic inflammation after ETI therapy may reveal important translational insights. This study aims to profile systemic inflammatory changes and relate these to the well-documented improvements observed with ETI therapy. Methods We conducted a single-centre longitudinal study with 57 CF subjects initiating ETI therapy. All participants were Phe508del homozygous or Phe508del/minimal function. Blood samples were collected pre-ETI and 3–12 months post-therapy initiation. Analyses included mass spectrometry-based proteomics, a multiplex immunoassay, and flow cytometry for peripheral immune cell counts and phenotype. Controls samples were provided by 29 age-matched healthy controls. Results Systemic inflammation reduced with ETI therapy; however, the immune profile remained distinct from healthy controls. ETI reduced neutrophil counts and was associated with a more mature, less inflammatory phenotype, as well as a shift towards an immune resolving state associated with increased CD206 expression. Cytokines known to influence neutrophil levels reduced with therapy. Despite ETI therapy, neutrophil and monocyte counts remained elevated compared with healthy controls. There was no obvious association between the ETI-related improvements in systemic inflammation and lung function. Conclusions Patients with CF showed evidence of persisting systemic inflammation despite ETI therapy, which may have long-term potentially adverse effects on respiratory and other organ systems.

10 March 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
NTNicola Tempest
Nicola Tempest
JSJamie Soul
Jamie Soul
CHChristopher J. Hill
Christopher J. Hill
EGEva Caamaño Gutiérrez
Eva Caamaño Gutiérrez
DHDharani K. Hapangama
Dharani K. Hapangama
Recurrent implantation failure (RIF) is a devastating condition that leaves many undergoing fertility treatment childless. The human endometrium is receptive to a blastocyst for a brief period, the window of implantation. Critical knowledge underpinning biological processes leading to RIF, essential for effective treatment, is lacking. We employed spatial transcriptomics to define region- and cell-type-specific differences in endometrial gene expression in luteinizing hormone timed biopsies between women with RIF (n = 8) and fertile controls (FC) (n = 8). Differentially expressed genes (DEGs) were identified when comparing endometrial regions between FC and RIF (685 luminal epithelium, 293 glandular epithelium, 419 subluminal stroma, 264 functionalis stroma, 1,125 subluminal stromal CD45 + leukocytes, and 1,049 functionalis stromal CD56 + leukocytes). Only 57 DEGs were common to all subregions and cell types, which highlights that multiple DEGs are lost when the endometrium is examined as a single entity. When RIF-specific DEGs were leveraged against knowledge from mouse genetic models, genes associated with aberrant embryo implantation phenotypes were observed, mostly in immune cell populations. Dysregulated pathways in specific endometrial regions included the “WNT signaling pathway,” altered in the functionalis and subluminal stroma. “Response to estradiol” and “ovulation cycle” pathways were dysregulated in the subluminal stroma. In silico drug screening identified potential compounds that can reverse the RIF gene expression profile (e.g., raloxifene, bisoprolol). Our findings, in a well-characterized cohort, highly endorse consideration of each endometrial region and cell type as separate entities. Ignoring individual regions and composite cell populations will overlook important aberrations, forego potential treatment targets, and lead to research waste pursuing clinically irrelevant treatment options.

1 February 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
SPShaun Pennington
Shaun Pennington
DFD. M. Ferreira
D. M. Ferreira
EGEva Caamaño Gutiérrez
Eva Caamaño Gutiérrez
JRJ. Reiné
J. Reiné
CHC. Hewitt
C. Hewitt
MGM. A. Gordon
M. A. Gordon
Vaccination with weakened strains of Salmonella may protect against other infections.